FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Apotex Aripiprazole Tablets Recall

Aripiprazole Tablets, USP 15 mg tablets, packaged in a) 1000 count bottle

Apotex Corp. · Weston, FL

Risk level
Class II
Reported by FDA
Nov 25, 2020
Recall ID
D-0106-2021
Check your lot numberHow we source this data

Summary

Apotex recalled Aripiprazole Tablets starting Nov 11, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0106-2021 on Nov 25, 2020. Reason: Failed Dissolution Specifications: Out of specification for dissolution. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Out of specification for dissolution.

Product description

Aripiprazole Tablets, USP 15 mg tablets, packaged in a) 1000 count bottle, NDC 60505-2675-8; b) 30 count bottle, NDC 60505-2675-3; Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326

Lot numbers, UPCs & expiration codes

a) PZ6716 Exp. 02/2021; b) PZ6715 Exp. 02/2021

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0106-2021
Classification
Class II
Status
Terminated
Recall initiated
Nov 11, 2020
FDA report date
Nov 25, 2020
Quantity
a)552 bottles; b) 3192 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Corp.

Original FDA data

Every field from FDA enforcement report D-0106-2021, exactly as published.

Show all FDA fields
City
Weston
State
FL
Status
Terminated
Country
United States
Event ID
86736
Address
2400 N Commerce Pkwy Ste 400
Code information
a) PZ6716 Exp. 02/2021; b) PZ6715 Exp. 02/2021
Postal code
33326-3253
Report date
Nov 25, 2020
Product type
Drugs
Recall number
D-0106-2021
Classification
Class II
Recalling firm
Apotex Corp.
Product quantity
a)552 bottles; b) 3192 bottles
Termination date
Aug 11, 2021
Reason for recall
Failed Dissolution Specifications: Out of specification for dissolution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Aripiprazole Tablets, USP 15 mg tablets, packaged in a) 1000 count bottle, NDC 60505-2675-8; b) 30 count bottle, NDC 60505-2675-3; Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Nov 11, 2020
Initial firm notification
Letter
Center classification date
Nov 24, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0106-2021, published Nov 25, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls